Input,Term,mean_hetesim_score,count,term_uniID
ANGPT2,angiogenesis,0.598166722,8,angiogenesis
ANGPT2,angiogenesis,0.598166722,8,angiogenesis
ANGPT2,collagen-containing extracellular matrix,0.598166722,8,ECM component
ANGPT2,glomerulus vasculature development,0.598166722,8,glomerulus development
ANGPT2,negative regulation of angiogenesis,0.598166722,8,angiogenesis
ANGPT2,negative regulation of blood vessel endothelial cell migration,0.598166722,8,cell migration
ANGPT2,negative regulation of cell-substrate adhesion,0.598166722,8,cell adhesion
ANGPT2,negative regulation of positive chemotaxis,0.598166722,8,chemotaxis
ANGPT2,positive regulation of angiogenesis,0.598166722,8,angiogenesis
ANGPT2,regulation of angiogenesis,0.598166722,8,angiogenesis
ANGPT2,vascular endothelial growth factor receptor binding,0.598166722,8,growth factor signaling
ANXA7,autophagy,0.561385621,8,autophagy
ANXA7,calcium-dependent phospholipid binding,0.561385621,8,calcium channel activity
ANXA7,calcium-dependent protein binding,0.561385621,8,calcium channel activity
ANXA7,calcium ion binding,0.561385621,8,calcium channel activity
ANXA7,collagen-containing extracellular matrix,0.561385621,8,ECM component
ANXA7,intracellular calcium ion homeostasis,0.561385621,8,calcium channel activity
ANXA7,response to calcium ion,0.561385621,8,calcium channel activity
CCL1,antimicrobial humoral immune response mediated by antimicrobial peptide,0.583627953,12,immune response
CCL1,CCR chemokine receptor binding,0.583627953,12,chemotaxis
CCL1,cellular response to interleukin-1,0.583627953,12,cell response to cytokines
CCL1,cellular response to interleukin-17,0.583627953,12,cell response to cytokines
CCL1,chemokine activity,0.583627953,12,chemotaxis
CCL1,chemokine activity,0.583627953,12,chemotaxis
CCL1,chemokine-mediated signaling pathway,0.583627953,12,chemotaxis
CCL1,chemotaxis,0.583627953,12,chemotaxis
CCL1,cytokine activity,0.583627953,12,cell response to cytokines
CCL1,eosinophil chemotaxis,0.583627953,12,chemotaxis
CCL1,immune response,0.583627953,12,immune response
CCL1,inflammatory response,0.583627953,12,inflammatory response
CCL1,lymphocyte chemotaxis,0.583627953,12,chemotaxis
CCL1,monocyte chemotaxis,0.583627953,12,chemotaxis
CCL1,neutrophil chemotaxis,0.583627953,12,chemotaxis
CCL1,positive regulation of cytosolic calcium ion concentration,0.583627953,12,calcium channel activity
CCL1,positive regulation of ERK1 and ERK2 cascade,0.583627953,12,ERK/MAPK signaling response
CCL1,positive regulation of inflammatory response,0.583627953,12,inflammatory response
CCL1,positive regulation of interleukin-17 production,0.583627953,12,cell response to cytokines
CCL1,positive regulation of monocyte chemotaxis,0.583627953,12,chemotaxis
CCL22,antimicrobial humoral immune response mediated by antimicrobial peptide,0.553272043,8,immune response
CCL22,CCR chemokine receptor binding,0.553272043,8,chemotaxis
CCL22,cellular response to interleukin-1,0.553272043,8,cell response to cytokines
CCL22,chemokine activity,0.553272043,8,chemotaxis
CCL22,chemokine-mediated signaling pathway,0.553272043,8,chemotaxis
CCL22,chemotaxis,0.553272043,8,chemotaxis
CCL22,cytokine activity,0.553272043,8,cell response to cytokines
CCL22,eosinophil chemotaxis,0.553272043,8,chemotaxis
CCL22,immune response,0.553272043,8,immune response
CCL22,inflammatory response,0.553272043,8,inflammatory response
CCL22,lymphocyte chemotaxis,0.553272043,8,chemotaxis
CCL22,monocyte chemotaxis,0.553272043,8,chemotaxis
CCL22,neutrophil chemotaxis,0.553272043,8,chemotaxis
CCL22,positive regulation of ERK1 and ERK2 cascade,0.553272043,8,ERK/MAPK signaling response
CD226,cell adhesion,0.557081132,12,cell adhesion
CD226,cell adhesion molecule binding,0.557081132,12,cell adhesion
CD226,cytokine production,0.557081132,12,cell response to cytokines
CD226,cytokine production,0.557081132,12,cell response to cytokines
CD226,natural killer cell cytokine production,0.557081132,12,cell response to cytokines
CD226,positive regulation of immunoglobulin mediated immune response,0.557081132,12,immune response
CD226,positive regulation of immunoglobulin mediated immune response,0.557081132,12,immune response
CD226,positive regulation of mast cell activation,0.557081132,12,T cell mediated response
CD226,positive regulation of mast cell activation,0.557081132,12,T cell mediated response
CD226,positive regulation of natural killer cell cytokine production,0.557081132,12,cell response to cytokines
CD226,positive regulation of natural killer cell cytokine production,0.557081132,12,cell response to cytokines
CD226,positive regulation of T cell receptor signaling pathway,0.557081132,12,T cell mediated response
CD226,positive regulation of T cell receptor signaling pathway,0.557081132,12,T cell mediated response
CD80,immune response,0.533585031,8,immune response
CD80,negative regulation of T cell mediated immunity,0.533585031,8,T cell mediated response
CD80,negative regulation of T cell proliferation,0.533585031,8,T cell mediated response
CD80,positive regulation of alpha-beta T cell proliferation,0.533585031,8,T cell mediated response
CD80,positive regulation of T cell proliferation,0.533585031,8,T cell mediated response
CD80,positive regulation of T cell proliferation,0.533585031,8,T cell mediated response
CD80,positive regulation of T cell proliferation,0.533585031,8,T cell mediated response
CD80,protein complex involved in cell adhesion,0.533585031,8,cell adhesion
CD80,T cell activation,0.533585031,8,T cell mediated response
CD80,T cell costimulation,0.533585031,8,T cell mediated response
CD80,T cell costimulation,0.533585031,8,T cell mediated response
CREG1,autophagy,0.653876499,8,autophagy
CREG1,insulin-like growth factor receptor binding,0.653876499,8,growth factor signaling
CTLA4,adaptive immune response,0.598067711,8,immune response
CTLA4,immune response,0.598067711,8,immune response
CTLA4,immune system process,0.598067711,8,immune response
CTLA4,negative regulation of regulatory T cell differentiation,0.598067711,8,T cell mediated response
CTLA4,negative regulation of regulatory T cell differentiation,0.598067711,8,T cell mediated response
CTLA4,negative regulation of T cell proliferation,0.598067711,8,T cell mediated response
CTLA4,positive regulation of apoptotic process,0.598067711,8,apoptotic process
CTLA4,protein complex involved in cell adhesion,0.598067711,8,cell adhesion
CTLA4,regulation of T cell proliferation,0.598067711,8,T cell mediated response
CTLA4,T cell receptor signaling pathway,0.598067711,8,T cell mediated response
DSPP,cellular response to cell-matrix adhesion,0.56627109,8,cell adhesion
DSPP,collagen-containing extracellular matrix,0.56627109,8,ECM component
DSPP,extracellular matrix,0.56627109,8,ECM component
DSPP,gene expression involved in extracellular matrix organization,0.56627109,8,ECM component
DSPP,negative regulation of mesenchymal cell apoptotic process,0.56627109,8,apoptotic process
DSPP,positive regulation of calcium ion import,0.56627109,8,calcium channel activity
DUSP5,negative regulation of MAPK cascade,0.538327636,8,ERK/MAPK signaling response
EGFR,cell-cell adhesion,0.531664798,8,cell adhesion
EGFR,cellular response to epidermal growth factor stimulus,0.531664798,8,growth factor signaling
EGFR,cellular response to growth factor stimulus,0.531664798,8,growth factor signaling
EGFR,cerebral cortex cell migration,0.531664798,8,cell migration
EGFR,epidermal growth factor binding,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor binding,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor binding,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor activity,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor activity,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor activity,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor activity,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor activity,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor signaling pathway,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor signaling pathway,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor signaling pathway,0.531664798,8,growth factor signaling
EGFR,epidermal growth factor receptor signaling pathway,0.531664798,8,growth factor signaling
EGFR,negative regulation of apoptotic process,0.531664798,8,apoptotic process
EGFR,negative regulation of apoptotic process,0.531664798,8,apoptotic process
EGFR,nitric-oxide synthase regulator activity,0.531664798,8,response to nitric oxide
EGFR,positive regulation of canonical Wnt signaling pathway,0.531664798,8,Wnt/beta-catenin pathway
EGFR,positive regulation of cell migration,0.531664798,8,cell migration
EGFR,positive regulation of cell population proliferation,0.531664798,8,cell proliferation
EGFR,positive regulation of ERK1 and ERK2 cascade,0.531664798,8,ERK/MAPK signaling response
EGFR,positive regulation of MAPK cascade,0.531664798,8,ERK/MAPK signaling response
EGFR,positive regulation of NIK/NF-kappaB signaling,0.531664798,8,NF-kappaB factor activity
EGFR,positive regulation of nitric oxide mediated signal transduction,0.531664798,8,response to nitric oxide
EGFR,positive regulation of superoxide anion generation,0.531664798,8,response to oxidative stress
EGFR,regulation of ERK1 and ERK2 cascade,0.531664798,8,ERK/MAPK signaling response
EGFR,regulation of nitric-oxide synthase activity,0.531664798,8,response to nitric oxide
EGFR,response to calcium ion,0.531664798,8,calcium channel activity
F13A1,collagen-containing extracellular matrix,0.578597229,8,ECM component
FCER2,B cell antigen processing and presentation,0.590110693,8,antigen processing
FCER2,Fc receptor-mediated immune complex endocytosis,0.590110693,8,immune response
FCER2,immune response,0.590110693,8,immune response
FCER2,macrophage activation,0.590110693,8,macrophage signaling response
FCER2,positive regulation of humoral immune response mediated by circulating immunoglobulin,0.590110693,8,immune response
FCER2,positive regulation of nitric-oxide synthase activity,0.590110693,8,response to nitric oxide
FCER2,positive regulation of nitric-oxide synthase biosynthetic process,0.590110693,8,response to nitric oxide
FOXF1,cell-cell adhesion,0.535268301,8,cell adhesion
FOXF1,cellular response to cytokine stimulus,0.535268301,8,cell response to cytokines
FOXF1,extracellular matrix organization,0.535268301,8,ECM component
FOXF1,mesenchyme migration,0.535268301,8,cell migration
FOXF1,negative regulation of inflammatory response,0.535268301,8,inflammatory response
FOXF1,negative regulation of mast cell degranulation,0.535268301,8,T cell mediated response
FOXF1,positive regulation of cell migration,0.535268301,8,cell migration
FOXF1,positive regulation of cell-substrate adhesion,0.535268301,8,cell adhesion
FOXF1,smooth muscle cell differentiation,0.535268301,8,cell differentiation
HEY2,cardiac muscle cell apoptotic process,0.561476008,12,apoptotic process
HEY2,negative regulation of cardiac muscle cell apoptotic process,0.561476008,12,apoptotic process
HEY2,negative regulation of Notch signaling pathway,0.561476008,12,Notch signaling response
HEY2,negative regulation of Notch signaling pathway,0.561476008,12,Notch signaling response
HEY2,Notch signaling involved in heart development,0.561476008,12,Notch signaling response
HEY2,Notch signaling pathway,0.561476008,12,Notch signaling response
HEY2,Notch signaling pathway,0.561476008,12,Notch signaling response
HEY2,Notch signaling pathway,0.561476008,12,Notch signaling response
IER3,negative regulation of apoptotic process,0.546511994,8,apoptotic process
IER3,negative regulation of inflammatory response,0.546511994,8,inflammatory response
ITGB1,adherens junction,0.532442829,8,junction assembly
ITGB1,calcium-independent cell-matrix adhesion,0.532442829,8,cell adhesion
ITGB1,calcium ion binding,0.532442829,8,calcium channel activity
ITGB1,cell adhesion,0.532442829,8,cell adhesion
ITGB1,cell adhesion mediated by integrin,0.532442829,8,cell adhesion
ITGB1,cell adhesion mediated by integrin,0.532442829,8,cell adhesion
ITGB1,cell adhesion molecule binding,0.532442829,8,cell adhesion
ITGB1,cell-matrix adhesion,0.532442829,8,cell adhesion
ITGB1,cell-matrix adhesion,0.532442829,8,cell adhesion
ITGB1,cell-matrix adhesion,0.532442829,8,cell adhesion
ITGB1,cell-matrix adhesion,0.532442829,8,cell adhesion
ITGB1,cell migration,0.532442829,8,cell migration
ITGB1,cell migration involved in sprouting angiogenesis,0.532442829,8,cell migration
ITGB1,C-X3-C chemokine binding,0.532442829,8,chemotaxis
ITGB1,C-X3-C chemokine binding,0.532442829,8,chemotaxis
ITGB1,fibroblast migration,0.532442829,8,cell migration
ITGB1,germ cell migration,0.532442829,8,cell migration
ITGB1,negative regulation of apoptotic process,0.532442829,8,apoptotic process
ITGB1,negative regulation of cell population proliferation,0.532442829,8,cell proliferation
ITGB1,positive regulation of angiogenesis,0.532442829,8,angiogenesis
ITGB1,positive regulation of apoptotic process,0.532442829,8,apoptotic process
ITGB1,positive regulation of cell migration,0.532442829,8,cell migration
ITGB1,positive regulation of fibroblast migration,0.532442829,8,cell migration
KAT2B,negative regulation of cell population proliferation,0.535610105,15,cell proliferation
LGALS1,apoptotic process,0.577453373,8,apoptotic process
LGALS1,collagen-containing extracellular matrix,0.577453373,8,ECM component
LGALS1,positive regulation of apoptotic process,0.577453373,8,apoptotic process
LGALS1,positive regulation of inflammatory response,0.577453373,8,inflammatory response
LGALS1,positive regulation of viral entry into host cell,0.577453373,8,T cell mediated response
LGALS1,T cell costimulation,0.577453373,8,T cell mediated response
NFKBIA,cellular response to cytokine stimulus,0.652933245,8,cell response to cytokines
NFKBIA,cytoplasmic sequestering of NF-kappaB,0.652933245,8,NF-kappaB factor activity
NFKBIA,cytoplasmic sequestering of NF-kappaB,0.652933245,8,NF-kappaB factor activity
NFKBIA,I-kappaB kinase/NF-kappaB signaling,0.652933245,8,NF-kappaB factor activity
NFKBIA,negative regulation of macrophage derived foam cell differentiation,0.652933245,8,macrophage signaling response
NFKBIA,negative regulation of NF-kappaB transcription factor activity,0.652933245,8,NF-kappaB factor activity
NFKBIA,negative regulation of Notch signaling pathway,0.652933245,8,Notch signaling response
NFKBIA,NF-kappaB binding,0.652933245,8,NF-kappaB factor activity
NFKBIA,NF-kappaB binding,0.652933245,8,NF-kappaB factor activity
NFKBIA,NIK/NF-kappaB signaling,0.652933245,8,NF-kappaB factor activity
NFKBIA,Notch signaling pathway,0.652933245,8,Notch signaling response
NFKBIA,positive regulation of inflammatory response,0.652933245,8,inflammatory response
NFKBIA,regulation of cell population proliferation,0.652933245,8,cell proliferation
NFKBIA,toll-like receptor 4 signaling pathway,0.652933245,8,TLR pathway
NTF4,growth factor activity,0.542841598,8,growth factor signaling
NTF4,negative regulation of neuron apoptotic process,0.542841598,8,apoptotic process
NTF4,nerve growth factor receptor binding,0.542841598,8,growth factor signaling
NTF4,nerve growth factor signaling pathway,0.542841598,8,growth factor signaling
PNLIPRP2,calcium ion binding,0.57521717,8,calcium channel activity
PRLH,fat cell differentiation,0.591904591,8,T cell mediated response
RIPK2,adaptive immune response,0.566280025,8,immune response
RIPK2,apoptotic process,0.566280025,8,apoptotic process
RIPK2,"CD4-positive, alpha-beta T cell proliferation",0.566280025,8,T cell mediated response
RIPK2,chemokine production,0.566280025,8,chemotaxis
RIPK2,cytokine-mediated signaling pathway,0.566280025,8,cell response to cytokines
RIPK2,ERK1 and ERK2 cascade,0.566280025,8,ERK/MAPK signaling response
RIPK2,ERK1 and ERK2 cascade,0.566280025,8,ERK/MAPK signaling response
RIPK2,I-kappaB kinase/NF-kappaB signaling,0.566280025,8,NF-kappaB factor activity
RIPK2,immature T cell proliferation in thymus,0.566280025,8,T cell mediated response
RIPK2,immune system process,0.566280025,8,immune response
RIPK2,innate immune response,0.566280025,8,immune response
RIPK2,innate immune response,0.566280025,8,immune response
RIPK2,innate immune response,0.566280025,8,immune response
RIPK2,interleukin-2 production,0.566280025,8,cell response to cytokines
RIPK2,interleukin-6 production,0.566280025,8,cell response to cytokines
RIPK2,macrophage cytokine production,0.566280025,8,cell response to cytokines
RIPK2,positive regulation of apoptotic process,0.566280025,8,apoptotic process
RIPK2,"positive regulation of CD4-positive, alpha-beta T cell proliferation",0.566280025,8,T cell mediated response
RIPK2,positive regulation of chemokine production,0.566280025,8,chemotaxis
RIPK2,positive regulation of cytokine-mediated signaling pathway,0.566280025,8,cell response to cytokines
RIPK2,positive regulation of ERK1 and ERK2 cascade,0.566280025,8,ERK/MAPK signaling response
RIPK2,positive regulation of ERK1 and ERK2 cascade,0.566280025,8,ERK/MAPK signaling response
RIPK2,positive regulation of I-kappaB kinase/NF-kappaB signaling,0.566280025,8,NF-kappaB factor activity
RIPK2,positive regulation of I-kappaB kinase/NF-kappaB signaling,0.566280025,8,NF-kappaB factor activity
RIPK2,positive regulation of I-kappaB kinase/NF-kappaB signaling,0.566280025,8,NF-kappaB factor activity
RIPK2,positive regulation of immature T cell proliferation in thymus,0.566280025,8,T cell mediated response
RIPK2,positive regulation of interleukin-1 beta production,0.566280025,8,cell response to cytokines
RIPK2,positive regulation of interleukin-2 production,0.566280025,8,cell response to cytokines
RIPK2,positive regulation of interleukin-6 production,0.566280025,8,cell response to cytokines
RIPK2,positive regulation of macrophage cytokine production,0.566280025,8,cell response to cytokines
RIPK2,positive regulation of NF-kappaB transcription factor activity,0.566280025,8,NF-kappaB factor activity
RIPK2,positive regulation of NF-kappaB transcription factor activity,0.566280025,8,NF-kappaB factor activity
RIPK2,positive regulation of stress-activated MAPK cascade,0.566280025,8,ERK/MAPK signaling response
RIPK2,positive regulation of T-helper 1 type immune response,0.566280025,8,immune response
RIPK2,regulation of apoptotic process,0.566280025,8,apoptotic process
RIPK2,response to interleukin-1,0.566280025,8,cell response to cytokines
RIPK2,response to interleukin-12,0.566280025,8,cell response to cytokines
RIPK2,response to interleukin-18,0.566280025,8,cell response to cytokines
RIPK2,stress-activated MAPK cascade,0.566280025,8,ERK/MAPK signaling response
RIPK2,T cell proliferation,0.566280025,8,T cell mediated response
RIPK2,T cell receptor signaling pathway,0.566280025,8,T cell mediated response
RIPK2,toll-like receptor 2 signaling pathway,0.566280025,8,TLR pathway
RIPK2,toll-like receptor 4 signaling pathway,0.566280025,8,TLR pathway
SERPINB1,collagen-containing extracellular matrix,0.58288039,8,ECM component
SERPINB1,inflammatory response,0.58288039,8,inflammatory response
SERPINB1,negative regulation of interleukin-1 beta production,0.58288039,8,cell response to cytokines
SERPINB1,negative regulation of interleukin-1 beta production,0.58288039,8,cell response to cytokines
SERPINB1,regulation of innate immune response,0.58288039,8,immune response
SERPINB1,negative regulation of interleukin-1 beta production,0.58288039,8,cell response to cytokines
SERPINB1,negative regulation of interleukin-1 beta production,0.58288039,8,cell response to cytokines
SERPINB1,negative regulation of interleukin-1 beta production,0.58288039,8,cell response to cytokines
SERPINB1,negative regulation of interleukin-1 beta production,0.58288039,8,cell response to cytokines
SESN1,cellular oxidant detoxification,0.552328322,8,response to oxidative stress
SESN1,oxidoreductase activity,0.552328322,8,response to oxidative stress
SNAP23,adherens junction,0.64523171,8,junction assembly
SNAP23,histamine secretion by mast cell,0.64523171,8,T cell mediated response
STK16,cellular response to transforming growth factor beta stimulus,0.610496439,8,growth factor signaling
SUCNR1,interleukin-1 beta production,0.568118008,8,cell response to cytokines
SUCNR1,interleukin-1 beta production,0.568118008,8,cell response to cytokines
SUCNR1,macrophage activation involved in immune response,0.568118008,8,immune response
SUCNR1,macrophage cytokine production,0.568118008,8,cell response to cytokines
SUCNR1,positive regulation of chemotaxis,0.568118008,8,chemotaxis
SUCNR1,positive regulation of inflammatory response,0.568118008,8,inflammatory response
SUCNR1,response to calcium ion,0.568118008,8,calcium channel activity
TAP,actin cytoskeleton organization,0.675352193,12,actin cytoskeleton
TAP,adaptive immune response,0.675352193,12,immune response
TAP,immune system process,0.675352193,12,immune response
TMSB10,actin cytoskeleton organization,0.571898549,11,actin cytoskeleton
TMSB10,regulation of cell migration,0.571898549,11,cell migration
TYK2,cell differentiation,0.762783472,8,cell differentiation
TYK2,cytokine-mediated signaling pathway,0.762783472,8,cell response to cytokines
TYK2,cytokine receptor binding,0.762783472,8,cell response to cytokines
TYK2,immune response,0.762783472,8,immune response
TYK2,interleukin-12-mediated signaling pathway,0.762783472,8,cell response to cytokines
TYK2,interleukin-12 receptor complex,0.762783472,8,cell response to cytokines
TYK2,interleukin-23 receptor complex,0.762783472,8,cell response to cytokines
TYK2,positive regulation of interleukin-17 production,0.762783472,8,cell response to cytokines
TYK2,positive regulation of natural killer cell proliferation,0.762783472,8,cell proliferation
TYK2,positive regulation of NK T cell proliferation,0.762783472,8,T cell mediated response
TYK2,positive regulation of NK T cell proliferation,0.762783472,8,T cell mediated response
TYK2,positive regulation of receptor signaling pathway via JAK-STAT,0.762783472,8,JAK-STAT pathway
TYK2,positive regulation of T cell proliferation,0.762783472,8,T cell mediated response
TYK2,positive regulation of T cell proliferation,0.762783472,8,T cell mediated response
TYK2,positive regulation of T-helper 17 type immune response,0.762783472,8,immune response
TYK2,receptor signaling pathway via JAK-STAT,0.762783472,8,JAK-STAT pathway
VEGFA,adherens junction,0.563661532,8,junction assembly
VEGFA,angiogenesis,0.563661532,8,angiogenesis
VEGFA,angiogenesis,0.563661532,8,angiogenesis
VEGFA,angiogenesis,0.563661532,8,angiogenesis
VEGFA,angiogenesis,0.563661532,8,angiogenesis
VEGFA,angiogenesis involved in coronary vascular morphogenesis,0.563661532,8,angiogenesis
VEGFA,apoptotic process,0.563661532,8,apoptotic process
VEGFA,basophil chemotaxis,0.563661532,8,chemotaxis
VEGFA,cell-cell adhesion,0.563661532,8,cell adhesion
VEGFA,cell chemotaxis,0.563661532,8,chemotaxis
VEGFA,cell differentiation,0.563661532,8,cell differentiation
VEGFA,cell migration,0.563661532,8,cell migration
VEGFA,cell migration,0.563661532,8,cell migration
VEGFA,cell migration involved in sprouting angiogenesis,0.563661532,8,cell migration
VEGFA,cell population proliferation,0.563661532,8,cell proliferation
VEGFA,cellular response to vascular endothelial growth factor stimulus,0.563661532,8,growth factor signaling
VEGFA,cellular response to vascular endothelial growth factor stimulus,0.563661532,8,growth factor signaling
VEGFA,cytokine activity,0.563661532,8,cell response to cytokines
VEGFA,endothelial cell chemotaxis,0.563661532,8,chemotaxis
VEGFA,endothelial cell migration,0.563661532,8,cell migration
VEGFA,extracellular matrix binding,0.563661532,8,ECM component
VEGFA,growth factor activity,0.563661532,8,growth factor signaling
VEGFA,growth factor activity,0.563661532,8,growth factor signaling
VEGFA,growth factor activity,0.563661532,8,growth factor signaling
VEGFA,growth factor binding,0.563661532,8,growth factor signaling
VEGFA,induction of positive chemotaxis,0.563661532,8,chemotaxis
VEGFA,induction of positive chemotaxis,0.563661532,8,chemotaxis
VEGFA,kidney development,0.563661532,8,kidney development
VEGFA,lymphangiogenesis,0.563661532,8,angiogenesis
VEGFA,lymphangiogenesis,0.563661532,8,angiogenesis
VEGFA,macrophage differentiation,0.563661532,8,macrophage signaling response
VEGFA,monocyte differentiation,0.563661532,8,macrophage signaling response
VEGFA,motor neuron migration,0.563661532,8,cell migration
VEGFA,negative regulation of adherens junction organization,0.563661532,8,junction assembly
VEGFA,negative regulation of apoptotic process,0.563661532,8,apoptotic process
VEGFA,negative regulation of apoptotic process,0.563661532,8,apoptotic process
VEGFA,negative regulation of cell-cell adhesion,0.563661532,8,cell adhesion
VEGFA,negative regulation of cell-cell adhesion mediated by cadherin,0.563661532,8,cell adhesion
VEGFA,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.563661532,8,apoptotic process
VEGFA,negative regulation of fat cell differentiation,0.563661532,8,T cell mediated response
VEGFA,negative regulation of neuron apoptotic process,0.563661532,8,apoptotic process
VEGFA,platelet-derived growth factor receptor binding,0.563661532,8,growth factor signaling
VEGFA,positive chemotaxis,0.563661532,8,chemotaxis
VEGFA,positive chemotaxis,0.563661532,8,chemotaxis
VEGFA,positive regulation of angiogenesis,0.563661532,8,angiogenesis
VEGFA,positive regulation of angiogenesis,0.563661532,8,angiogenesis
VEGFA,positive regulation of angiogenesis,0.563661532,8,angiogenesis
VEGFA,positive regulation of blood vessel endothelial cell migration,0.563661532,8,cell migration
VEGFA,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.563661532,8,angiogenesis
VEGFA,positive regulation of cell adhesion,0.563661532,8,cell adhesion
VEGFA,positive regulation of cell migration,0.563661532,8,cell migration
VEGFA,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,positive regulation of cell migration involved in sprouting angiogenesis,0.563661532,8,cell migration
VEGFA,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,positive regulation of endothelial cell migration,0.563661532,8,cell migration
VEGFA,positive regulation of ERK1 and ERK2 cascade,0.563661532,8,ERK/MAPK signaling response
VEGFA,positive regulation of ERK1 and ERK2 cascade,0.563661532,8,ERK/MAPK signaling response
VEGFA,positive regulation of lymphangiogenesis,0.563661532,8,angiogenesis
VEGFA,positive regulation of MAPK cascade,0.563661532,8,ERK/MAPK signaling response
VEGFA,positive regulation of p38MAPK cascade,0.563661532,8,ERK/MAPK signaling response
VEGFA,positive regulation of positive chemotaxis,0.563661532,8,chemotaxis
VEGFA,positive regulation of sprouting angiogenesis,0.563661532,8,angiogenesis
VEGFA,positive regulation of trophoblast cell migration,0.563661532,8,T cell mediated response
VEGFA,positive regulation of vascular endothelial growth factor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,positive regulation of vascular permeability,0.563661532,8,vascular permeability
VEGFA,positive regulation of vascular permeability,0.563661532,8,vascular permeability
VEGFA,regulation of endothelial cell differentiation,0.563661532,8,cell differentiation
VEGFA,regulation of nitric oxide mediated signal transduction,0.563661532,8,response to nitric oxide
VEGFA,sprouting angiogenesis,0.563661532,8,angiogenesis
VEGFA,sprouting angiogenesis,0.563661532,8,angiogenesis
VEGFA,T-helper 1 type immune response,0.563661532,8,immune response
VEGFA,vascular endothelial growth factor receptor 1 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor 1 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor 1 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor 2 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor 2 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor 2 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor 2 binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor-2 signaling pathway,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor binding,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor receptor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor signaling pathway,0.563661532,8,growth factor signaling
VEGFA,vascular endothelial growth factor signaling pathway,0.563661532,8,growth factor signaling
